Health Canada has released a draft revised Quality Guide for Natural Health Products (NHPs) for public consultation, representing the first comprehensive update to the guidance since 2015. The consultation is open from 20 July 2026 to 20 September 2026, giving manufacturers, Product Licence holders, ingredient suppliers, contract manufacturers, testing laboratories, and regulatory professionals an opportunity… Continue reading Health Canada Releases Draft Revised Quality Guide for Natural Health Products: What Manufacturers Need to Know
Category: GMP Compliance
Health Canada’s Red Tape Reduction Initiative: What the Latest NHP Regulatory Changes Mean for Manufacturers
Health Canada has launched a new consultation under its Red Tape Reduction Initiative, inviting feedback from stakeholders on opportunities to simplify regulatory processes while maintaining Canada’s high standards for consumer safety. For manufacturers, importers, private-label brand owners, and regulatory professionals working with Natural Health Products (NHPs), this initiative represents an important opportunity to influence the… Continue reading Health Canada’s Red Tape Reduction Initiative: What the Latest NHP Regulatory Changes Mean for Manufacturers
FDA One-Day Inspectional Assessments: What FDA-Regulated Companies Need to Know in 2026
The U.S. Food and Drug Administration (FDA) has officially launched a new inspection initiative known as One-Day Inspectional Assessments (ODIAs), signaling an important shift in how FDA-regulated companies may be inspected moving into 2026 and beyond. For manufacturers, exporters, and FDA-regulated businesses supplying products to the United States, this development reflects the FDA’s growing focus… Continue reading FDA One-Day Inspectional Assessments: What FDA-Regulated Companies Need to Know in 2026